{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:53:03Z","timestamp":1724806383678},"reference-count":33,"publisher":"Scientific Scholar","issue":"01","license":[{"start":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T00:00:00Z","timestamp":1567555200000},"content-version":"vor","delay-in-days":976,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurosciences in Rural Practice"],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Background: Symptomatic intracranial hemorrhage (sICH) is the most unwanted adverse event in patients with acute ischemic stroke who received intravenous recombinant tissue plasminogen activator (i.v. rt-PA). Many tool scores are available to predict the probability of sICH. Among those scores, the Sugar, Early infarct sign, hyperDense middle cerebral artery, Age, Neurologic deficit (SEDAN) gives the highest area under the curve-receiver operating characteristic value. Objective: We aimed to examine any factors other than the SEDAN score to predict the probability of sICH. Methods: Patients with acute ischemic stroke treated with i.v. rt-PA within 4.5 h time window from January 2010 to July 2012 were evaluated. Compiling demographic data, risk factors, and comorbidity (hypertension, diabetes mellitus, dyslipidemia, atrial fibrillation (AF), ischemic heart disease, valvular heart disease, previous stroke, gout, smoking cigarette, drinking alcoholic beverage, family history of stroke, and family history of ischemic heart disease), computed tomography scan of patients prior to treatment with rt-PA, and assessing the National Institutes of Health Stroke Scale (NIHSS) score for the purpose of calculating SEDAN score were analyzed. Results: Of 314 patients treated with i.v. rt-PA, there were 46 ICH cases (14.6%) with 14 sICH (4.4%) and 32 asymptomatic intracranial hemorrhage cases (10.2%). The rate of sICH occurrence was increased in accordance with the increase in the SEDAN score and AF. Age over 75 years, early infarction, hyperdense cerebral artery, baseline blood sugar more than 12 mmol\/l, NIHSS as 10 or more, and AF were the risk factors to develop sICH after treated with rt-PA at 1.535, 2.501, 1.093, 1.276, 1.253, and 2.492 times, respectively. Conclusions: Rather than the SEDAN score, AF should be a predictor of sICH in patients with acute ischemic stroke after i.v. rt-PA treatment in Thai population.<\/jats:p>","DOI":"10.4103\/0976-3147.193548","type":"journal-article","created":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T07:30:25Z","timestamp":1478590225000},"page":"049-054","source":"Crossref","is-referenced-by-count":5,"title":["Not only the Sugar, Early infarct sign, hyperDense middle cerebral artery, Age, Neurologic deficit score but also atrial fibrillation is predictive for symptomatic intracranial hemorrhage after intravenous recombinant tissue plasminogen activator"],"prefix":"10.25259","volume":"08","author":[{"given":"Sombat","family":"Muengtaweepongsa","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Neurology, Stroke Excellence Center, Thammasat University, Pathum Thani, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pornpoj","family":"Prapa-Anantachai","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Neurology, Stroke Excellence Center, Thammasat University, Pathum Thani, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pornpat A.","family":"Dharmasaroja","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Neurology, Stroke Excellence Center, Thammasat University, Pathum Thani, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2019,9,4]]},"reference":[{"key":"key-10.4103\/0976-3147.193548-1","doi-asserted-by":"crossref","unstructured":"Al-Senani FM, Grotta JC, Kasner SE, Gorelick PB. Thrombolytic Therapies. Ch. 13. Philadelphia: Butterworth-Heinemann; 2004. p. 267-81.","DOI":"10.1016\/S1877-3419(09)70088-1"},{"key":"key-10.4103\/0976-3147.193548-2","first-page":"1581","volume-title":"The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group","author":"Tissue","year":"1995","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0976-3147.193548-3","first-page":"1245","volume-title":"Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II).Second European-Australasian Acute Stroke Study Investigators","author":"Hacke","year":"1998","journal-title":"Lancet"},{"key":"key-10.4103\/0976-3147.193548-4","first-page":"1317","volume-title":"Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke","author":"Hacke","year":"2008","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0976-3147.193548-5","first-page":"863","volume-title":"Thrombolytic therapy for acute stroke in the United Kingdom: Experience from the safe implementation of thrombolysis in stroke (SITS) register","author":"Lees","year":"2008","journal-title":"QJM"},{"key":"key-10.4103\/0976-3147.193548-6","first-page":"240","volume-title":"Improved prediction of poor outcome after thrombolysis using conservative definitions of symptomatic hemorrhage","author":"Gumbinger","year":"2012","journal-title":"Stroke"},{"key":"key-10.4103\/0976-3147.193548-7","first-page":"549","volume-title":"Thrombolytic therapy in acute ischemic stroke in Asia: The first prospective evaluation","author":"Suwanwela","year":"2006","journal-title":"Clin Neurol Neurosurg"},{"key":"key-10.4103\/0976-3147.193548-8","first-page":"42","volume-title":"Outcomes of intravenous thrombolytic therapy for acute ischemic stroke with an integrated acute stroke referral network: Initial experience of a community-based hospital in a developing country","author":"Muengtaweepongsa","year":"2012","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"key-10.4103\/0976-3147.193548-9","first-page":"710681","volume-title":"Age predicts functional outcome in acute stroke patients with rt-PA treatment","author":"Chindaprasirt","year":"2013","journal-title":"ISRN Neurol"},{"key":"key-10.4103\/0976-3147.193548-10","first-page":"181","volume-title":"External validation of the SEDAN score: The real world practice of a single center","author":"Muengtaweepongsa","year":"2015","journal-title":"Ann Indian Acad Neurol","ISSN":"http:\/\/id.crossref.org\/issn\/0972-2327","issn-type":"print"},{"key":"key-10.4103\/0976-3147.193548-11","first-page":"1417","volume-title":"The HAT score: A simple grading scale for predicting hemorrhage after thrombolysis","author":"Lou","year":"2008","journal-title":"Neurology"},{"key":"key-10.4103\/0976-3147.193548-12","first-page":"331","volume-title":"A risk score to predict intracranial hemorrhage after recombinant tissue plasminogen activator for acute ischemic stroke","author":"Cucchiara","year":"2008","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"key-10.4103\/0976-3147.193548-13","first-page":"634","volume-title":"Symptomatic intracranial hemorrhage after stroke thrombolysis: The SEDAN score","author":"Strbian","year":"2012","journal-title":"Ann Neurol"},{"key":"key-10.4103\/0976-3147.193548-14","first-page":"1524","volume-title":"Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: Safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score","author":"Mazya","year":"2012","journal-title":"Stroke"},{"key":"key-10.4103\/0976-3147.193548-15","first-page":"2293","volume-title":"Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator","author":"Menon","year":"2012","journal-title":"Stroke"},{"key":"key-10.4103\/0976-3147.193548-16","first-page":"412","volume-title":"Predicting outcomes after transient ischemic attack and stroke","author":"Rempe","year":"2014","journal-title":"Continuum (Minneap Minn)"},{"key":"key-10.4103\/0976-3147.193548-17","first-page":"296","volume-title":"Risk of symptomatic intracerebral hemorrhage after thrombolysis with rt-PA: The SEDAN score","author":"Br\u00fcning","year":"2015","journal-title":"CNS Neurosci Ther"},{"key":"key-10.4103\/0976-3147.193548-18","first-page":"239","volume-title":"Predicting risk of symptomatic intracerebral hemorrhage and mortality after treatment with recombinant tissue-plasminogen activator using SEDAN score","author":"Al-Khaled","year":"2016","journal-title":"Acta Neurol Scand"},{"key":"key-10.4103\/0976-3147.193548-19","first-page":"126","volume-title":"Clinical study on HAT and SEDAN score scales and related risk factors for predicting hemorrhagic transformation following thrombolysis in acute ischemic stroke","author":"Wei","year":"2015","journal-title":"Chin J Contemp Neurol Neurosurg"},{"key":"key-10.4103\/0976-3147.193548-20","first-page":"752","volume-title":"Symptomatic intracranial hemorrhage after stroke thrombolysis: Comparison of prediction scores","author":"Strbian","year":"2014","journal-title":"Stroke"},{"key":"key-10.4103\/0976-3147.193548-21","first-page":"189","volume-title":"Validation assessment of risk tools to predict outcome after thrombolytic therapy for acute ischemic stroke","author":"Van","year":"2014","journal-title":"Clin Neurol Neurosurg"},{"key":"key-10.4103\/0976-3147.193548-22","first-page":"1595","volume-title":"External validation of the SEDAN score for prediction of intracerebral hemorrhage in stroke thrombolysis","author":"Mazya","year":"2013","journal-title":"Stroke"},{"key":"key-10.4103\/0976-3147.193548-23","first-page":"224","volume-title":"Thrombolysis risk prediction: Applying the SITS-SICH and SEDAN scores in South African patients","author":"von","year":"2014","journal-title":"Cardiovasc J Afr"},{"key":"key-10.4103\/0976-3147.193548-24","first-page":"870","volume-title":", Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association","author":"Jauch","year":"2013","journal-title":"Stroke"},{"key":"key-10.4103\/0976-3147.193548-25","doi-asserted-by":"crossref","unstructured":"Adams HP Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.","DOI":"10.1161\/01.STR.24.1.35"},{"key":"key-10.4103\/0976-3147.193548-26","first-page":"1460","volume-title":"Atrial fibrillation and stroke: Prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project)","author":"Sandercock","year":"1992","journal-title":"BMJ"},{"key":"key-10.4103\/0976-3147.193548-27","first-page":"1765","volume-title":"Acute stroke with atrial fibrillation.The Copenhagen stroke study","author":"J\u00f8rgensen","year":"1996","journal-title":"Stroke"},{"key":"key-10.4103\/0976-3147.193548-28","first-page":"389","volume-title":"Pathophysiological determinants of worse stroke outcome in atrial fibrillation","author":"Tu","year":"2010","journal-title":"Cerebrovasc Dis"},{"key":"key-10.4103\/0976-3147.193548-29","first-page":"6","volume-title":"IV t-PA therapy in acute stroke patients with atrial fibrillation","author":"Kimura","year":"2009","journal-title":"J Neurol Sci"},{"key":"key-10.4103\/0976-3147.193548-30","first-page":"999","volume-title":"Is atrial fibrillation associated with poor outcome after thrombolysis?","author":"San\u00e1k","year":"2010","journal-title":"J Neurol"},{"key":"key-10.4103\/0976-3147.193548-31","first-page":"1454","volume-title":"Relationship between chronic atrial fibrillation and worse outcomes in stroke patients after intravenous thrombolysis","author":"Seet","year":"2011","journal-title":"Arch Neurol"},{"key":"key-10.4103\/0976-3147.193548-32","first-page":"457","volume-title":"Guidelines for management of ischaemic stroke and transient ischaemic attack 2008","author":"European","year":"2008","journal-title":"Cerebrovasc Dis"},{"key":"key-10.4103\/0976-3147.193548-33","first-page":"246","volume-title":"Stroke: Haemorrhage risk after thrombolysis \u2013 The SEDAN score","author":"Lyden","year":"2012","journal-title":"Nat Rev Neurol"}],"container-title":["Journal of Neurosciences in Rural Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.4103\/0976-3147.193548.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T04:19:13Z","timestamp":1691209153000},"score":1,"resource":{"primary":{"URL":"https:\/\/ruralneuropractice.com\/not-only-the-sugar-early-infarct-sign-hyperdense-middle-cerebral-artery-age-neurologic-deficit-score-but-also-atrial-fibrillation-is-predictive-for-symptomatic-intracranial-hemorrhage-after-intrav\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":33,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2019,9,4]]},"published-print":{"date-parts":[[2017,1]]}},"URL":"https:\/\/doi.org\/10.4103\/0976-3147.193548","relation":{},"ISSN":["0976-3147","0976-3155"],"issn-type":[{"value":"0976-3147","type":"print"},{"value":"0976-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}